Back
Speaker illustration

Miss Belen Alvarez

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

Presentations

Optimal medical treatment and cardiac resynchronization therapy? Prognostic implications. HF-CardioCHUS Registry

Event: ESC Congress 2017

Topic: Resynchronisation therapy

Session: Cardiac resynchronisation therapy

Access
Like
Thumbnail

Cardiac resynchronization Therapy pacemaker or defibrillator? Long term follow-upoutcomes

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access
Like
Thumbnail

Atrial fibrillation at follow-up does not worsen the prognosis of cardiac resynchronization therapy

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access
Like
Thumbnail

Prognostic value of left ventricular ejection fraction after cardiac resynchronization therapy: mid-range ejection fraction also in the echocardiographic response of cardiac resynchronization therapy

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access
Like
Thumbnail

Optimal medical treatment and cardiac resynchronization therapy? Prognostic implications. HF-CardioCHUS Registry

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources